PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35480991-8	2022	Results: The results indicated that the effect of ketamine on CI was primarily associated with the target of alpha-synuclein (SNCA), muscarinic acetylcholine receptor M1 (CHRM1) and nitric oxide synthase 1 (NOS1).	Ketamine	50-58	synuclein alpha	Homo sapiens	109-124	
35480991-8	2022	Results: The results indicated that the effect of ketamine on CI was primarily associated with the target of alpha-synuclein (SNCA), muscarinic acetylcholine receptor M1 (CHRM1) and nitric oxide synthase 1 (NOS1).	Ketamine	50-58	synuclein alpha	Homo sapiens	126-130	
35480991-12	2022	Three pivotal targets involving 298 proteins, SNCA, CHRM1 and NOS1, have emerged as multi-target mechanisms for ketamine in CI therapy.	Ketamine	112-120	synuclein alpha	Homo sapiens	46-50	
27590136-9	2017	Protein carbonyl was elevated in the PFC, amygdala, and NAc after ketamine administration.	Ketamine	66-74	synuclein alpha	Homo sapiens	56-59	
27590136-10	2017	Ketamine also increased nitrite/nitrate in the PFC, hippocampus, amygdala, and NAc.	Ketamine	0-8	synuclein alpha	Homo sapiens	79-82	
27590136-11	2017	Myeloperoxidase activity increased in the hippocampus and NAc after ketamine administration.	Ketamine	68-76	synuclein alpha	Homo sapiens	58-61